These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9005353)
1. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis]. König F; Löble M; Wolfersdorf M Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353 [TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients. Hawley CJ; Quick SJ; Ratnam S; Pattinson HA; McPhee S Int Clin Psychopharmacol; 1996 Sep; 11(3):187-91. PubMed ID: 8923097 [TBL] [Abstract][Full Text] [Related]
3. Serotonin syndrome in the elderly after antidepressive monotherapy. Fischer P J Clin Psychopharmacol; 1995 Dec; 15(6):440-2. PubMed ID: 8748434 [No Abstract] [Full Text] [Related]
4. Serotonin syndrome--clomipramine too soon after moclobemide? Gillman PK Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136 [No Abstract] [Full Text] [Related]
5. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Kline SS; Mauro LS; Scala-Barnett DM; Zick D Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897 [No Abstract] [Full Text] [Related]
6. Serotonin syndrome with moclobemide-fluoxetine combination. Benazzi F Pharmacopsychiatry; 1996 Jul; 29(4):162. PubMed ID: 8858717 [No Abstract] [Full Text] [Related]
7. Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome. Shad MU; Preskorn SH J Clin Psychopharmacol; 1998 Aug; 18(4):346-7. PubMed ID: 9690705 [No Abstract] [Full Text] [Related]
8. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? Steele D; Keltner NL; McGuiness TM Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073 [No Abstract] [Full Text] [Related]
9. Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline. Wu ML; Deng JF J Chin Med Assoc; 2009 Aug; 72(8):446-9. PubMed ID: 19687003 [TBL] [Abstract][Full Text] [Related]
12. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression. König F; Wolfersdorf M; Löble M; Wössner S; Hauger B Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. Uguz F; Sonmez EÖ Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome: a diagnosis easily missed. McDonough CM; Swift G; Managan B; Sheehan JD Ir Med J; 2000; 93(5):152-4. PubMed ID: 11072926 [TBL] [Abstract][Full Text] [Related]
16. [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine]. Rüth U; Mayer-Rosa J; Schlamp D; Freisleder FJ Z Kinder Jugendpsychiatr Psychother; 2000 May; 28(2):105-8. PubMed ID: 10863766 [TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome and drug combinations: focus on MAOI and RIMA. Hilton SE; Maradit H; Möller HJ Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):113-9. PubMed ID: 9224903 [TBL] [Abstract][Full Text] [Related]
18. Hypothalamic pathology in the neuroleptic malignant syndrome. Horn E; Lach B; Lapierre Y; Hrdina P Am J Psychiatry; 1988 May; 145(5):617-20. PubMed ID: 2895986 [TBL] [Abstract][Full Text] [Related]